| Katherine B Holbrook, APRN | |
|
2600 Elms Plantation Blvd, North Charleston, SC 29406-9164 | |
| (800) 491-0909 | |
| (843) 782-4044 |
| Full Name | Katherine B Holbrook |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 2600 Elms Plantation Blvd, North Charleston, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770019531 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 22452 (Tennessee) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 20938 (South Carolina) | Primary |
| Entity Name | Sc House Calls Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518048859 PECOS PAC ID: 6800994807 Enrollment ID: O20070613000821 |
News Archive
Sepracor Inc. today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency now anticipates completing its review of the STEDESA™ (eslicarbazepine acetate) New Drug Application (NDA) on April 30, 2010, which is a three-month extension to the original Prescription Drug User Fee Act (PDUFA) date of January 30, 2010.
Do some people have special "susceptibility" genes that make them vulnerable to obesity and diabetes, triggered by poor diet and less exercise?
This week, TCA Cellular Therapy's Medical Director Gabriel Lasala, M.D. presents advances in a proprietary combination adult stem cell treatment for acute myocardial infarction at the Society for Cardiovascular Angiography and Interventions (SCAI) scientific conference in San Diego.
Adiponectin, a collagen-like protein secreted by fat cells, derives from the ADIPOQ gene. Variations in this gene may increase risk for type 2 diabetes, cardiovascular disease, and various cancers. A new study that links specific variations in the ADIPOQ gene to either higher or lower colorectal cancer risk is published in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Data from patients who are considered high-risk due to underlying clinical conditions and who cannot be treated with drug eluting stents and the accompanying requirement of long-term dual antiplatelet therapy showed positive safety and short- and long-term clinical outcomes following treatment with OrbusNeich's Genous Stent, according to a study published online in EuroIntervention.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine B Holbrook, APRN 1624 Main Street, Agape Senior Primary Care, Inc., Columbia, SC 29201-2818 Ph: (803) 726-2283 | Katherine B Holbrook, APRN 2600 Elms Plantation Blvd, North Charleston, SC 29406-9164 Ph: (800) 491-0909 |
News Archive
Sepracor Inc. today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency now anticipates completing its review of the STEDESA™ (eslicarbazepine acetate) New Drug Application (NDA) on April 30, 2010, which is a three-month extension to the original Prescription Drug User Fee Act (PDUFA) date of January 30, 2010.
Do some people have special "susceptibility" genes that make them vulnerable to obesity and diabetes, triggered by poor diet and less exercise?
This week, TCA Cellular Therapy's Medical Director Gabriel Lasala, M.D. presents advances in a proprietary combination adult stem cell treatment for acute myocardial infarction at the Society for Cardiovascular Angiography and Interventions (SCAI) scientific conference in San Diego.
Adiponectin, a collagen-like protein secreted by fat cells, derives from the ADIPOQ gene. Variations in this gene may increase risk for type 2 diabetes, cardiovascular disease, and various cancers. A new study that links specific variations in the ADIPOQ gene to either higher or lower colorectal cancer risk is published in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Data from patients who are considered high-risk due to underlying clinical conditions and who cannot be treated with drug eluting stents and the accompanying requirement of long-term dual antiplatelet therapy showed positive safety and short- and long-term clinical outcomes following treatment with OrbusNeich's Genous Stent, according to a study published online in EuroIntervention.
› Verified 3 days ago
Mr. Richard Dale Brinson, MSN, APRN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9330 Medical Plaza Dr, North Charleston, SC 29406 Phone: 843-847-4595 | |
Kimberly Lynn Rhoton, ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4050 Bridge View Dr, Suite 500, Perimeter Center, North Charleston, SC 29405 Phone: 843-746-4030 | |
Whitney Naramore Huff, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4975 Lacross Rd Ste 110, North Charleston, SC 29406 Phone: 843-797-1941 Fax: 843-574-1698 | |
Andrietta Wright Barnett, DNP FNP-C PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4000 Faber Place Dr Ste 110, North Charleston, SC 29405 Phone: 843-501-1099 | |
Mrs. Dodi Lynn Baum, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9267 Medical Plaza Dr Ste G, North Charleston, SC 29406 Phone: 843-797-3636 | |
Tina Withrow, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2910 Tricom St, North Charleston, SC 29406 Phone: 843-572-9211 Fax: 843-572-0457 | |
Hannah Dweikat, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4920 Ohear Ave Ste 101, North Charleston, SC 29405 Phone: 843-856-3784 |